- Home
- ECBK vs ANVS Comparison
ECBK vs ANVS Comparison
Compare ECBK & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECBK
- ANVS
- Stock Information
- Founded
- ECBK 1919
- ANVS 2008
- Country
- ECBK United States
- ANVS United States
- Employees
- ECBK N/A
- ANVS N/A
- Industry
- ECBK Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ECBK Finance
- ANVS Health Care
- Exchange
- ECBK Nasdaq
- ANVS Nasdaq
- Market Cap
- ECBK 123.9M
- ANVS 110.4M
- IPO Year
- ECBK N/A
- ANVS 2020
- Fundamental
- Price
- ECBK $14.38
- ANVS $8.43
- Analyst Decision
- ECBK
- ANVS Strong Buy
- Analyst Count
- ECBK 0
- ANVS 5
- Target Price
- ECBK N/A
- ANVS $30.60
- AVG Volume (30 Days)
- ECBK 13.8K
- ANVS 152.5K
- Earning Date
- ECBK 11-07-2024
- ANVS 11-06-2024
- Dividend Yield
- ECBK N/A
- ANVS N/A
- EPS Growth
- ECBK 74.17
- ANVS N/A
- EPS
- ECBK 0.42
- ANVS N/A
- Revenue
- ECBK $24,752,000.00
- ANVS N/A
- Revenue This Year
- ECBK N/A
- ANVS N/A
- Revenue Next Year
- ECBK N/A
- ANVS N/A
- P/E Ratio
- ECBK $34.15
- ANVS N/A
- Revenue Growth
- ECBK 2.68
- ANVS N/A
- 52 Week Low
- ECBK $9.82
- ANVS $4.53
- 52 Week High
- ECBK $14.84
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- ECBK 58.93
- ANVS 51.10
- Support Level
- ECBK $14.28
- ANVS $7.84
- Resistance Level
- ECBK $14.84
- ANVS $8.36
- Average True Range (ATR)
- ECBK 0.38
- ANVS 0.53
- MACD
- ECBK 0.02
- ANVS 0.04
- Stochastic Oscillator
- ECBK 72.94
- ANVS 36.31
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.